Literature DB >> 31448207

Machine-learning based classification of glioblastoma using delta-radiomic features derived from dynamic susceptibility contrast enhanced magnetic resonance images: Introduction.

Jiwoong Jeong1, Liya Wang2,3, Bing Ji2, Yang Lei1, Arif Ali1, Tian Liu1, Walter J Curran1, Hui Mao2, Xiaofeng Yang1.   

Abstract

BACKGROUND: Glioblastoma is the most aggressive brain tumor with poor prognosis. The purpose of this study is to improve the tissue characterization of these highly heterogeneous tumors using delta-radiomic features of images from dynamic susceptibility contrast enhanced (DSC) magnetic resonance imaging (MRI).
METHODS: Twenty-five patients with histopathologically confirmed to be 13 high-grade (HG) and 12 low-grade (LG) gliomas who underwent the standard brain tumor MRI protocol, including DSC MRI, were included. Tumor regions on all DSC MRI images were registered to and contoured in T2-weighted fluid-attenuated inversion recovery (FLAIR) images. These contours and its contralateral regions of the normal tissue were used to extract delta-radiomic features before applying feature selection. The most informative and non-redundant features were selected to train a random forest to differentiate HG and LG gliomas. Then a leave-one-out cross-validation random forest was applied to classify these tumors for grading. Finally, a majority-voting method was applied to reduce binarization bias and to combine the results of various feature lists.
RESULTS: Analysis of the predictions showed that the reported method consistently predicted the tumor grade of 24 out of 25 patients correctly (0.96). Finally, the mean prediction accuracy was 0.950±0.091 for HG and 0.850±0.255 for LG. The area under the receiver operating characteristic curve (AUC) was 0.94.
CONCLUSIONS: This study shows that delta-radiomic features derived from DSC MRI data can be used to characterize and determine the tumor grades. The radiomic features from DSC MRI may be used to elucidate the underlying tumor biology and response to therapy.

Entities:  

Keywords:  Machine learning; dynamic susceptibility contrast enhanced magnetic resonance imaging (DSC MRI); radiomics

Year:  2019        PMID: 31448207      PMCID: PMC6685811          DOI: 10.21037/qims.2019.07.01

Source DB:  PubMed          Journal:  Quant Imaging Med Surg        ISSN: 2223-4306


  24 in total

1.  The somatic genomic landscape of glioblastoma.

Authors:  Cameron W Brennan; Roel G W Verhaak; Aaron McKenna; Benito Campos; Houtan Noushmehr; Sofie R Salama; Siyuan Zheng; Debyani Chakravarty; J Zachary Sanborn; Samuel H Berman; Rameen Beroukhim; Brady Bernard; Chang-Jiun Wu; Giannicola Genovese; Ilya Shmulevich; Jill Barnholtz-Sloan; Lihua Zou; Rahulsimham Vegesna; Sachet A Shukla; Giovanni Ciriello; W K Yung; Wei Zhang; Carrie Sougnez; Tom Mikkelsen; Kenneth Aldape; Darell D Bigner; Erwin G Van Meir; Michael Prados; Andrew Sloan; Keith L Black; Jennifer Eschbacher; Gaetano Finocchiaro; William Friedman; David W Andrews; Abhijit Guha; Mary Iacocca; Brian P O'Neill; Greg Foltz; Jerome Myers; Daniel J Weisenberger; Robert Penny; Raju Kucherlapati; Charles M Perou; D Neil Hayes; Richard Gibbs; Marco Marra; Gordon B Mills; Eric Lander; Paul Spellman; Richard Wilson; Chris Sander; John Weinstein; Matthew Meyerson; Stacey Gabriel; Peter W Laird; David Haussler; Gad Getz; Lynda Chin
Journal:  Cell       Date:  2013-10-10       Impact factor: 41.582

2.  Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Registry of the United States, 1990-1994.

Authors:  T S Surawicz; B J McCarthy; V Kupelian; P J Jukich; J M Bruner; F G Davis
Journal:  Neuro Oncol       Date:  1999-01       Impact factor: 12.300

3.  Texture analysis of advanced non-small cell lung cancer (NSCLC) on contrast-enhanced computed tomography: prediction of the response to the first-line chemotherapy.

Authors:  Marco Ravanelli; Davide Farina; Mauro Morassi; Elisa Roca; Giuseppe Cavalleri; Gianfranco Tassi; Roberto Maroldi
Journal:  Eur Radiol       Date:  2013-07-09       Impact factor: 5.315

4.  Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics.

Authors:  Andrea Sottoriva; Inmaculada Spiteri; Sara G M Piccirillo; Anestis Touloumis; V Peter Collins; John C Marioni; Christina Curtis; Colin Watts; Simon Tavaré
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-14       Impact factor: 11.205

5.  Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.

Authors:  Christian Hartmann; Bettina Hentschel; Wolfgang Wick; David Capper; Jörg Felsberg; Matthias Simon; Manfred Westphal; Gabriele Schackert; Richard Meyermann; Torsten Pietsch; Guido Reifenberger; Michael Weller; Markus Loeffler; Andreas von Deimling
Journal:  Acta Neuropathol       Date:  2010-11-19       Impact factor: 17.088

6.  Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1.

Authors:  Roel G W Verhaak; Katherine A Hoadley; Elizabeth Purdom; Victoria Wang; Yuan Qi; Matthew D Wilkerson; C Ryan Miller; Li Ding; Todd Golub; Jill P Mesirov; Gabriele Alexe; Michael Lawrence; Michael O'Kelly; Pablo Tamayo; Barbara A Weir; Stacey Gabriel; Wendy Winckler; Supriya Gupta; Lakshmi Jakkula; Heidi S Feiler; J Graeme Hodgson; C David James; Jann N Sarkaria; Cameron Brennan; Ari Kahn; Paul T Spellman; Richard K Wilson; Terence P Speed; Joe W Gray; Matthew Meyerson; Gad Getz; Charles M Perou; D Neil Hayes
Journal:  Cancer Cell       Date:  2010-01-19       Impact factor: 31.743

7.  Radiogenomic analysis of breast cancer using MRI: a preliminary study to define the landscape.

Authors:  Shota Yamamoto; Daniel D Maki; Ronald L Korn; Michael D Kuo
Journal:  AJR Am J Roentgenol       Date:  2012-09       Impact factor: 3.959

8.  IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas.

Authors:  Sumihito Nobusawa; Takuya Watanabe; Paul Kleihues; Hiroko Ohgaki
Journal:  Clin Cancer Res       Date:  2009-09-15       Impact factor: 12.531

9.  Ultrasound GLCM texture analysis of radiation-induced parotid-gland injury in head-and-neck cancer radiotherapy: an in vivo study of late toxicity.

Authors:  Xiaofeng Yang; Srini Tridandapani; Jonathan J Beitler; David S Yu; Emi J Yoshida; Walter J Curran; Tian Liu
Journal:  Med Phys       Date:  2012-09       Impact factor: 4.071

10.  Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach.

Authors:  Hugo J W L Aerts; Emmanuel Rios Velazquez; Ralph T H Leijenaar; Chintan Parmar; Patrick Grossmann; Sara Carvalho; Sara Cavalho; Johan Bussink; René Monshouwer; Benjamin Haibe-Kains; Derek Rietveld; Frank Hoebers; Michelle M Rietbergen; C René Leemans; Andre Dekker; John Quackenbush; Robert J Gillies; Philippe Lambin
Journal:  Nat Commun       Date:  2014-06-03       Impact factor: 14.919

View more
  13 in total

Review 1.  Radiomics for precision medicine in glioblastoma.

Authors:  Kiran Aftab; Faiqa Binte Aamir; Saad Mallick; Fatima Mubarak; Whitney B Pope; Tom Mikkelsen; Jack P Rock; Syed Ather Enam
Journal:  J Neurooncol       Date:  2022-01-12       Impact factor: 4.130

Review 2.  A Survey of Radiomics in Precision Diagnosis and Treatment of Adult Gliomas.

Authors:  Peng Du; Hongyi Chen; Kun Lv; Daoying Geng
Journal:  J Clin Med       Date:  2022-06-30       Impact factor: 4.964

3.  Cascaded mutual enhancing networks for brain tumor subregion segmentation in multiparametric MRI.

Authors:  Shadab Momin; Yang Lei; Zhen Tian; Justin Roper; Jolinta Lin; Shannon Kahn; Hui-Kuo Shu; Jeffrey Bradley; Tian Liu; Xiaofeng Yang
Journal:  Phys Med Biol       Date:  2022-04-11       Impact factor: 4.174

4.  4D-CT deformable image registration using multiscale unsupervised deep learning.

Authors:  Yang Lei; Yabo Fu; Tonghe Wang; Yingzi Liu; Pretesh Patel; Walter J Curran; Tian Liu; Xiaofeng Yang
Journal:  Phys Med Biol       Date:  2020-04-20       Impact factor: 3.609

5.  Multimodal MRI synthesis using unified generative adversarial networks.

Authors:  Xianjin Dai; Yang Lei; Yabo Fu; Walter J Curran; Tian Liu; Hui Mao; Xiaofeng Yang
Journal:  Med Phys       Date:  2020-10-27       Impact factor: 4.071

6.  MRI radiomic signature predicts intracranial progression-free survival in patients with brain metastases of ALK-positive non-small cell lung cancer.

Authors:  Shijun Zhao; Donghui Hou; Xiaomin Zheng; Wei Song; Xiaoqing Liu; Sicong Wang; Lina Zhou; Xiuli Tao; Lv Lv; Qi Sun; Yujing Jin; Lieming Ding; Li Mao; Ning Wu
Journal:  Transl Lung Cancer Res       Date:  2021-01

7.  Exploring diagnostic performance of T2 mapping in diffuse glioma grading.

Authors:  Weibin Gu; Shiyuan Fang; Xinyi Hou; Ding Ma; Shaowu Li
Journal:  Quant Imaging Med Surg       Date:  2021-07

8.  Application of intraoperative B-mode ultrasound and shear wave elastography for glioma grading.

Authors:  Lu Yin; Linggang Cheng; Fumin Wang; Xueli Zhu; Yue Hua; Wen He
Journal:  Quant Imaging Med Surg       Date:  2021-06

9.  A Novel Intelligent System for Brain Tumor Diagnosis Based on a Composite Neutrosophic-Slantlet Transform Domain for Statistical Texture Feature Extraction.

Authors:  Shakhawan H Wady; Raghad Z Yousif; Harith R Hasan
Journal:  Biomed Res Int       Date:  2020-07-10       Impact factor: 3.411

10.  Radiomics Prediction of EGFR Status in Lung Cancer-Our Experience in Using Multiple Feature Extractors and The Cancer Imaging Archive Data.

Authors:  Lin Lu; Shawn H Sun; Hao Yang; Linning E; Pingzhen Guo; Lawrence H Schwartz; Binsheng Zhao
Journal:  Tomography       Date:  2020-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.